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The time-domain measures and power–spectral analysis of heart rate variability (HRV) are
classic conventional methods to assess the complex regulatory system between auto-
nomic nervous system and heart rate and are most widely used. There are abundant
scientiﬁc data about the prognostic signiﬁcance of the conventional measurements of
HRV in patients with various conditions, particularly with myocardial infarction. Some stud-
ies have suggested that some newer measures describing non-linear dynamics of heart
rate, such as fractal measures, may reveal prognostic information beyond that obtained by
the conventional measures of HRV. An ideal risk indicator could speciﬁcally predict sud-
den arrhythmic death as the implantable cardioverter-deﬁbrillator (ICD) therapy can prevent
such events. There are numerically more sudden deaths among post-infarction patients
with better preserved left ventricular function than in those with severe left ventricular
dysfunction. Recent data support the concept that HRV measurements, when analyzed
several weeks after acute myocardial infarction, predict life-threatening ventricular tach-
yarrhythmias in patients with moderately depressed left ventricular function. However,
well-designed prospective randomized studies are needed to evaluate whether the ICD
therapy based on the assessment of HRV alone or with other risk indicators improves the
patients’ prognosis. Several issues, such as the optimal target population, optimal timing of
HRV measurements, optimal methods of HRV analysis, and optimal cutpoints for different
HRV parameters, need clariﬁcation before the HRV analysis can be a widespread clinical
tool in risk stratiﬁcation.
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INTRODUCTION
Heart rate variability (HRV) describes the complex regulatory sys-
tem between heart rate and the autonomic nervous system. There
are several methods to measure HRV (Task Force of the Euro-
pean Society of Cardiology and the North American Society of
Pacing and Electrophysiology, 1996). The traditional statistical
methods and the power–spectral analysis of HRV are classic meth-
ods to measure HRV and are most widely used. The conventional
measures of HRV have been shown to provide prognostic infor-
mation in several patient populations (Kleiger et al., 1987; Bigger
et al., 1992, 1993; Fei et al., 1996; Zuanetti et al., 1996; Nolan
et al., 1998). The conventional measures of HRV cannot reveal
delicate changes in heart rate beat-to-beat dynamics. Therefore
several non-linear methods for measuring heart rate dynamics
have been developed (Saul et al., 1987; Goldberger, 1990b, 1996;
Skinner et al., 1993; Pincus and Goldberger, 1994; Peng et al., 1995;
Voss et al., 1998; Tuzcu et al., 2006; Norris et al., 2008a). Few of
these newer methods of HRV, such as the fractal-like scaling prop-
erty and the complexity, have been tested in well-designed studies,
which have included a relevant number of patients and have had
well-deﬁned endpoints. Some of these studies have suggested that
some of the non-linear measures of HRV work better than the tra-
ditional measures of HRV in predicting future adverse events in
various patient groups. The physiological background of the non-
linear measures of HRV is much less well understood than that
of the conventional measures of HRV. The non-linear methods of
HRV assess qualitative properties rather than the magnitude of the
heart rate dynamics.
Several other factors than the type of the parameter inﬂuence
the prognostic value of HRV measurements. The timing of the
HRV measurement after an acute myocardial infarction (AMI)
has a direct inﬂuence on the prognostic signiﬁcance of HRV due
to substantial electrical and mechanical remodeling after AMI
(Exner et al., 2007; Huikuri et al., 2009a). The prognostic value of
HRV variables is also dependent on the left ventricular function
and the severity of heart failure (Mäkikallio et al., 2001a, 2005).
HRV parameters analyzed from short-term recordings obtained
during controlled conditions yield somewhat different prognos-
tic information than the HRV variables analyzed from long-term
ambulatory 24-h recordings. It is also important to select appropri-
ate preprocessing methods for editing premature depolarizations
and irrelevant oscillations from RR interval time series in order to
obtain reliable and reproducible prognostic data for clinical pur-
poses (this is dealt in another review in the present issue). It is
noteworthy that HRV parameters work prognostically differently
in patients with different diseases and healthy subjects. The predic-
tive power of HRVvariables varies also depending onwhether total
mortality, different modes of mortality, or other adverse events
are selected as endpoints. Several novel methods to describe heart
rate dynamics, such as heart rate turbulence, have been developed
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(Schmidt et al., 1999). Their role in risk stratiﬁcation is discussed
in other reviews in this issue as is the inﬂuence of exercise on heart
rate dynamics.
During the past two decades the number of publications deal-
ing with HRV has exploded reaching at least over 14,000 at the
moment. The present review is focusing on some of these studies,
of which the majority have relevant number of patients and well-
deﬁned endpoints, and which elucidate the value of conventional
and non-linear methods of HRV in risk assessment.
HEART RATE VARIABILITY IN RISK EVALUATION
CLASSIC STUDIES APPLYING CONVENTIONAL METHODS OF HEART
RATE VARIABILITY ANALYSIS
The prognostic signiﬁcance of the conventional measures of HRV
in post-AMI patients is well established. Schneider and Costiloe
(1965) ﬁrst proposed that HRV is reduced in patients with AMI
and is associated with adverse prognosis. Wolf et al. (1978) found
a signiﬁcantly lower in-hospital mortality rate among the patients
with AMI, who had more pronounced sinus arrhythmia. Kleiger
et al. (1987) published the cornerstone study, where they showed
that decreased HRV measured by the SD of all normal-to-normal
RR-intervals (SDNN) analyzed from 24-h electrocardiographic
recordings predicts mortality in post-infarction patients. The
combination of reduced HRV and the occurrence of late poten-
tials was found to have a sensitivity of 58%, a positive predictive
accuracy of 33%, and a relative risk of 18.5 for arrhythmic events
in post-AMI patients (Farrell et al., 1991). In the study by Cripps
et al. (1991), which included 177 patients after AMI, the rela-
tive risk of sudden death or symptomatic sustained ventricular
tachycardia during a median follow-up of 16months was found
to be seven times greater in those with low baseline values of the
triangular index of HRV. In another study, after adjustment for
relevant clinical risk markers, the total, ultralow-frequency and
very-low-frequency powers of HRV remained a signiﬁcant and
powerful predictor of mortality after AMI (Bigger et al., 1992). In
433 survivors of ﬁrst AMI, Odemuyiwa et al. (1994) observed
that HRV was an independent predictor of sudden death and
total cardiac mortality only during the ﬁrst 6months of follow-
up. The results of the study including 226 consecutive patients
with AMI conﬁrmed the previous observations concerning the
association between decreased HRV and mortality after AMI and
suggested the importance of disturbance in sympathovagal regu-
lation unrelated to left ventricular function or infarct location as a
mechanism of high-risk (Vaishnav et al., 1994). Reduced HRV has
been found to be related to both arrhythmic and non-arrhythmic
death in post-AMI patients (Hartikainen et al., 1996). Fei et al.
(1996) showed in their study including 700 consecutive patients
after AMI that although the predictive accuracy of SDNN ana-
lyzed from 5-min short-term RR interval data for 1-year total
cardiac mortality was lower than that of the HRV index analyzed
from 24-h period, the SDNN short-term data could be used in
preselection of high-risk patients. Bigger et al. (1993) studied the
predictive value of the power–spectral measures of HRV obtained
from short from 2 to 15min electrocardiographic recordings in
715 post-AMI patients. They concluded that the power–spectral
measures of HRV obtained from short recordings are remark-
ably similar to those obtained from 24-h recordings and predict
all-causemortality and sudden cardiac death. Zuanetti et al. (1996)
evaluated the predictive value of several time-domain measures of
HRV for total and cardiovascular mortality in 567 patients with
AMI,whowere treatedwith thrombolytic therapy and followed up
for 1000 days. They concluded that time-domain indexes of HRV
retain their independent prognostic signiﬁcance even in post-AMI
patients of all ages treated with ﬁbrinolysis. Heart rate and HRV
analyzed from predischarge 24-h electrocardiographic recordings
were found to be more powerful predictors of mortality than ejec-
tion fraction in post-AMI patients in the study by Copie et al.
(1996). Disturbed autonomic modulation of heart rate seems to
be speciﬁcally related to susceptibility to ventricular ﬁbrillation,
but not to stablemonomorphic ventricular tachycardia, suggesting
that autonomic inﬂuences modify the presentation of malignant
ventricular tachyarrhythmia after previous myocardial infarction
(Perkiömäki et al., 1997).
The analysis of HRV can give an insight into various patho-
physiological processes including theprogressionof focal coronary
atherosclerosis (Huikuri et al., 1999a) and the angiographic sever-
ity of coronary artery disease (Hayano et al., 1990). Patients with
coronary artery disease may have decreased vagal activity (Airaksi-
nen et al., 1987) and abnormal circadian rhythm of HRV (Huikuri
et al., 1994). Furthermore, ischemia may be preceded by increased
sympathetic tone (Bernardi et al., 1988).
It is noteworthy that the HRV counterparts of autonomic dri-
ves are very different in patients with heart failure and in normal
subjects (van de Borne et al., 1997). However, there are a lot of
publications, which show that HRV is decreased in patients with
congestive heart failure (Saul et al., 1988; Casolo et al., 1989, 1991;
Kienzle et al., 1992; Nolan et al., 1992; Mortara et al., 1994). Saul
et al. (1988) observed decreased vagal, but relatively well preserved
sympathetic modulation of heart rate in patients with chronic
stable congestive heart failure. On the contrary, reduction of all
spectral components of HRV were found in patients with con-
gestive heart failure in the study by Casolo et al. (1991). Brouwer
et al. (1996) observed in 95 patients with mild to moderate heart
failure that abnormal Poincare plots were independent predictors
of all-cause and sudden cardiac death.
Hypertensive patients have been found to have increased low-
frequency components and reduced high-frequency components
of HRV (Guzetti et al., 1988). On the other hand, lower values of
low- and high-frequency power of HRV were observed in hyper-
tensive patients with left ventricular hypertrophy than in controls,
while ultralow- and very-low-frequency components were similar
in the groups (Petretta et al., 1995). Left ventricular hypertrophy
is a well known risk indicator, and HRV has been shown to be
inversely related to left ventricular mass index (Mandawat et al.,
1994, 1995; Petretta et al., 1995). However, not all studies have
conﬁrmed this ﬁnding (Perkiömäki et al., 1996).
Disturbances in cardiac autonomic regulation assessed by HRV
have been observed in several other conditions. Patients with dia-
betic neuropathy have decreased HRV (Wheeler and Watkins,
1973; Pfeifer et al., 1982; Smith, 1982). A reduced HRV in
patients with diabetes still yields long-term prognostic infor-
mation (Wheeler et al., 2002). In post-AMI patients the asso-
ciation between decreased HRV and long-term mortality has
been observed to be at least as strong in diabetic patients as in
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non-diabetic patients (Whang and Bigger, 2003). However, there
are also some data to suggest that including patients with dia-
betes decreases the association between HRV and mortality after
AMI (Stein et al., 2004). The measurement of HRV offers also
prognostic information in an elderly population beyond that pro-
vided by the assessment of conventional risk factors (Tsuji et al.,
1994). Patients with chronic renal failure (Axelrod et al., 1987;
Cloarec-Blanchard et al., 1992) have decreased HRV. Patients with
different neurological conditions, such as Parkinsonism (Kuroiwa
et al., 1983), multiple sclerosis (Neubauer and Gundersen, 1978),
and quadriplegia (Inoue et al., 1990), have also been observed to
have reduced HRV. Decreased HRV has been found in heart trans-
plant recipients, but allograft rejection may lead to increased HRV
(Sands et al., 1989).
STUDIES APPLYING NON-LINEAR METHODS OF HEART RATE
VARIABILITY AND NEWER STUDIES
The fractal measures are the non-linear measures of HRV, whose
prognostic signiﬁcance has most widely been assessed in clinical
studies including relevant number of patients and using well-
deﬁned endpoints. The fractalmeasures of HRVanalysis have been
shown to provide incremental prognostic information compared
with the conventional measures of heart rate ﬂuctuations. A basic
feature of a fractal system is scale-invariance, i.e., same features
repeat themselves on different measurement scales (Goldberger,
1996). Healthy subjects´ erratic ﬂuctuations of sinus rhythm
have fractal-like characteristics (Denton et al., 1990; Goldberger,
1990a).
Power-lawHRVanalysis is as a qualitativemeasure of the power
spectrum in the region of the ultralow- and very-low-frequency
bands obtained from long-term recordings. A plot of spectral
power and frequency on bi-logarithmic scale shows linear por-
tion between 10−4 and 10−2 Hz, and the slope of this relationship
reﬂects long-term fractal-like scaling characteristics of HRV (Saul
et al., 1987). Healthy subjects have power-law exponent values
around −1 (Saul et al., 1987; Bigger et al., 1996), and the value
of this slope has been observed to decrease with advancing age
(Pikkujämsä et al., 1999). The ﬁnding that denervated hearts have
a substantially steeper power-law slope emphasizes the important
role of the autonomic nervous system in determining the steepness
of the slope (Bigger et al., 1996). A steep power-law slope has been
shown to be a better predictor of all-cause mortality or arrhyth-
mic death than the traditional power–spectral bands in post-AMI
patients (Bigger et al., 1996), and a better predictor of mortality
than the traditional measurements of HRV in the elderly (Huikuri
et al., 1998).
Detrended ﬂuctuation analysis (DFA) quantiﬁes intrinsic
fractal-like correlation properties of dynamic systems (Peng et al.,
1994). Peng et al. (1995) have described the details of this method.
Brieﬂy, the RR interval variability in relation to a local trend is
analyzed in observation windows of different sizes in preprocessed
and integrated RR interval time series. The RR interval variabil-
ity is shown on a log–log scale as a function of the observation
window size. In the presence of scaling, this relationship has a
linear portion. The short-term scaling exponent (DFA1; for win-
dow sizes<11 beats) describes short-term scaling properties, and
the intermediate-term scaling exponent (DFA2; for window sizes
>11 beats) longer term scaling properties of the signal. Healthy
middle-aged subjects have the short-term scaling exponent val-
ues somewhat over or around 1 (Pikkujämsä et al., 2001). The
values of the short-term scaling exponent are determined by a
complex interplay of the parasympathetic and sympathetic auto-
nomic nervous system. Concomitant activation of both vagal and
sympathetic outﬂow has been shown to decrease the short-term
fractal scaling exponent resulting in a random heart rate behav-
ior (Tulppo et al., 2005). The physiological background of the
short-term scaling exponent has been discussed in detail elsewhere
(Huikuri et al., 2009b). Healthy elderly subjects may have changes
in the fractal correlation properties of heart rate dynamics (Iyen-
gar et al., 1996; Pikkujämsä et al., 1999), and the short-term scaling
exponent has also been observed to predict cardiac death in the
elderly (Mäkikallio et al., 2001b).
There is some evidence that the short-term fractal-like scaling
properties of heart rate dynamics analyzed by the DFA technique
can yield prognostic information beyond that obtained by the con-
ventionalmeasures of HRV. Studies inpost-AMIpatients have sug-
gested that decreased short-term scaling exponent is a better pre-
dictor of mortality than the conventional measurements of HRV
(Mäkikallio et al., 1999a; Huikuri et al., 2000) and that decreased
short-term scaling exponent values are associated with vulnerabil-
ity to ventricular tachycardia (Mäkikallio et al., 1997), ventricular
ﬁbrillation (Mäkikallio et al., 1999b), arrhythmic death, and non-
arrhythmic cardiac death (Huikuri et al., 2000). The prognostic
value of the short-term scaling exponent has also been shown in
a general post-AMI population without a marked left ventricu-
lar dysfunction and high proportion of patients on beta-blocking
medication (Tapanainen et al., 2002). Fractal HRV has been
observed to retain its prognostic value even when the vast major-
ity of the patients were taking beta-blockers after AMI (Jokinen
et al., 2003). Among the autonomic risk markers, the short-term
scaling exponent has been found to be the strongest predictor of
recurrent non-fatal coronary events after AMI (Perkiömäki et al.,
2008). Disturbed cardiac autonomic regulation represented by
reduced values of the short-term scaling exponent has been found
to predict perpetuating ventricular tachyarrhythmias, but not self-
terminating ventricular tachyarrhythmias in post-AMI patients
with moderate left ventricular dysfunction suggesting that per-
petuating and self-terminating ventricular tachyarrhythmias may
have differences in factors,whichmodify arrhythmias (Perkiömäki
et al., 2011; Figure 1). Figure 2 shows two typical cases of RR inter-
val behavior in high-risk patients with low short-term fractal scal-
ing exponent and one case with normal fractal scaling exponent.
Heart failure patients show loss of fractal organization in heart
rate dynamics (Peng et al., 1995), and this is associated with the
risk of death (Ho et al., 1997). Reduced short-term scaling expo-
nent is more closely related to the risk of mortality in patients
with less severe than in those with more advanced heart fail-
ure (Mäkikallio et al., 2001a). The short-term scaling exponent
has also been shown to predict long-term risk for heart failure
hospitalization after AMI (Perkiömäki et al., 2010).
The spontaneous onset of atrial ﬁbrillation in patients without
a structural heart disease is preceded by altered short-term fractal-
like scaling properties of HRV (Vikman et al., 1999), and the short-
term scaling exponent changes toward more random direction in
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FIGURE 1 | Cumulative proportional probability of perpetuating (left chart) and self-terminating (right chart) ventricular tachyarrhythmias (VTA) for
patients with the short-term scaling exponent obtained by the detrended fluctuation analysis (DFA1) ≤ or >0.77. Reproduced with a permission from
Perkiömäki et al. (2011).
FIGURE 2 | RR interval tachograms in two patients at high-risk for
cardiac mortality who have low short-term fractal scaling exponent (α;
left and middle) and one patient with low risk and normal short-term
fractal scaling exponent. Reproduced with a permission from Huikuri
et al. (2009b).
ectopic tachycardia reﬂecting disturbances in autonomic regula-
tion or in ectopic atrial pacemakers (Huikuri et al., 1999b).
Some of the non-linear measures of HRV, such as the
short-term scaling exponent, have some advantages over the
conventional measures of HRV considering risk stratiﬁcation
purposes. These advantages include: less dependency on heart
rate, less inter-individual and intra-individual variation (Perk-
iömäki et al., 2001c; Pikkujämsä et al., 2001; Maestri et al.,
2007), smaller relative changes of individual values over time
after AMI (Perkiömäki et al., 2001c), and relatively good
comparability of individual values between long-term and
short-term electrocardiographic recordings (Perkiömäki et al.,
2001b).
The cardiac arrhythmias and risk stratiﬁcation after acute
myocardial infarction (CARISMA) study included patients, who
had left ventricular ejection fraction ≤40% measured from 3 to
21 days afterAMI. Several HRV measures,when analyzed from 24-
h ECGs recorded at 6 weeks after the AMI, predicted the primary
endpoint of ventricular ﬁbrillation or symptomatic sustained ven-
tricular tachycardia.However, the short-termscaling exponentwas
the only HRV measure, when analyzed from 24-h ECGs recorded
at 1 week after the AMI, which signiﬁcantly predicted the pri-
mary endpoint. It is noteworthy that the arrhythmic endpoint
events were objectively detected using implantable loop recorders
in the CARISMA study (Huikuri et al., 2009a), whereas in most
of the previous studies arrhythmic events/sudden arrhythmic car-
diac death have been evaluated on clinical basis. In the recent
non-invasive risk assessment early after a myocardial infarction
(REFINE) study (Exner et al., 2007), which included post-AMI
patients with somewhat better preserved left ventricular function
than the CARISMA study, HRV measured from 10 to 14weeks
after the AMI tended to predict the primary endpoint of car-
diac death or resuscitated cardiac arrest, but had no association
with the primary endpoint when measured from 2 to 4weeks after
the AMI. These notions underline the importance of timing for
measurement of HRV after AMI.
The data on the prognostic signiﬁcance of the complexity mea-
sures of HRV are limited (Huikuri et al., 2009b). Decreased multi-
scale entropy of heart rate has been observed to predict mortality
in trauma patients (Norris et al., 2008a,b). There has been shown
to be association with reduced complexity in heart rate dynamics
and postoperative complications after vascular surgery (Fleisher
et al., 1993).Decreased complexity in heart rate behaviormeasured
by approximate entropy has been found to precede spontaneous
episodes of atrial ﬁbrillation in patients without structural heart
disease (Vikman et al., 1999) and in patients after coronary artery
bypass surgery (Hogue et al., 1998). Furthermore, the complexity
of heart rate dynamics has been observed to reduce during 1 year
follow-up after coronary artery bypass operation (Laitio et al.,
2006).
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USEFULNESS OF HEART RATE VARIABILITY IN CLINICAL
DECISION MAKING AND FUTURE PERSPECTIVES
Despite a large body of evidence documenting the predictive value
of various HRV indices, none of these methods are in widespread
clinical use at the moment. If patients would be risk stratiﬁed
to a therapy based on a HRV measurement, the therapy should
improve the patients’ outcome. Therefore it should be evaluated in
well-designed prospective randomized studies, whether the selec-
tion of the patients to the therapy based on potentially useful
HRV measurements improves the prognosis. An ideal risk strat-
iﬁer should speciﬁcally predict sudden arrhythmic death as an
implantable cardioverter-deﬁbrillator (ICD) therapy is effective in
preventing such events. The patients with severely depressed left
ventricular function are at highest risk for life-threatening ventric-
ular arrhythmias (Huikuri et al., 2001), however, it has been found
that HRV measurements work prognostically better in patients
with more preserved left ventricular function (Mäkikallio et al.,
2005) than in those with more severe left ventricular dysfunction.
Additionally, there is evidence to support the concept that dis-
turbed HRV predicts cardiac death in general and not speciﬁcally
sudden arrhythmic death in patients with severe left ventricular
dysfunction (Perkiömäki et al., 2001a; Zareba et al., 2003). On
the other hand, there are numerically more sudden deaths among
lower risk post-AMI patients with better preserved left ventricular
function (Huikuri et al., 2001). Furthermore, as described above
the results of theCARISMAstudy show thatmeasures of HRVana-
lyzed from electrocardiographic recordings obtained several weeks
after AMI predict life-threatening ventricular tachyarrhythmias
in post-AMI patients with moderately depressed left ventricular
function (Huikuri et al., 2009a). Taken together, the post-AMI
patients with moderate/mild left ventricular dysfunction would
be the best target population for future prospective studies aiming
to assess whether an intervention based on the assessment of HRV
improves the outcome. In the CARISMA study, according to the
receiver operator characteristics curve analysis, e.g., the short-term
scaling exponent analyzed from 24-h ECGs recorded at 6 weeks
after theAMI had the area under the curve of order of 0.75 for pre-
dicting life-threatening ventricular tachyarrhythmias. This can be
considered potentially useful accuracy for risk stratiﬁcation pur-
poses. However, the accuracy of this level does not simultaneously
allow both an excellent speciﬁcity and sensitivity for any selected
cutpoint. Therefore it would be important to try to ﬁnd additional
good risk markers, which could in combination with HRV mea-
surements increase the accuracy in predicting sudden arrhythmic
death. This is particularly important, if ICD therapy is considered
based on this risk stratiﬁcation strategy as ICD implantation and
therapy suffer from potential complications and discomfort and
are relatively expensive. Severely depressed left ventricular func-
tion is considered to be a sufﬁcient risk indicator for prophylactic
ICD implantation in post-AMI patients with acceptable numbers
needed to treat values for getting a beneﬁt (Moss et al., 2002;
Bardy et al., 2005). However, most of the post-AMI patients with
better preserved left ventricular function at high-risk for sudden
arrhythmic death do not get a primary prophylactic ICD ther-
apy. Taken together, it would therefore be justiﬁed to consider to
apply a cutpoint with compromised sensitivity of a HRV mea-
surement to get high speciﬁcity, high positive predictive accuracy,
and a low number needed to treat value in future prospective
randomized prophylactic ICD studies in post-AMI patients with
moderate/mild left ventricular dysfunction.
Despite many advancements, the analysis of HRV is still far
from routine clinical use. Before it can be a useful tool for clin-
icians, at least the following questions need clariﬁcation: what
would be the optimal timing for HRV analysis after AMI? What
would be the optimal target population for the use of HRV analy-
sis as a risk stratiﬁer? What method(s) should be used for HRV
analysis in clinical settings? What would be the optimal prepro-
cessing method for editing premature depolarizations for different
HRV parameters in different clinical settings? What would be the
recommendable cutpoints of selected HRV measurements for risk
stratiﬁcation purposes in different cardiac conditions for different
endpoints, in a same cardiac condition with different degree of left
ventricular dysfunction and heart failure, and in different age and
gender groups? What would be a recommendable length of ECG
recording? Under what kind of conditions should the ECG record-
ings be done? What is the accuracy of selected HRV measures in
predicting different adverse events in different cardiac conditions?
What would be the expected beneﬁts of HRV analysis to patients’
further evaluation and treatment? What would be the number
needed to treat value, e.g., to get beneﬁt from ICD therapy? Could
theHRVanalysis be used in the patients’ follow-up,etc.?Hopefully,
after further developments and standardization the HRV analysis
alone or with other risk indicators will soon serve as a useful tool
for risk stratiﬁcation.
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